Skip to Content

Meiji Holdings Co Ltd

2269: XTKS (JPN)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
JPY 3,553.00XhnpvdXnbhxtwp

Meiji's Profit Outlook Hinges on Probiotics Volume Recovery and China Distribution Expansion

Business Strategy and Outlook

Margin expansion through growth in value-added health foods and an enlarged overseas sales scale will continue to serve as a key driving force behind Meiji’s midterm growth. Meiji’s efforts to raise profitability through growth in premium functional foods, rationalization of its product portfolio, and cost-cutting initiatives have borne fruit, with margins expanding since bottoming in fiscal 2011. Yet the pace of margin expansion has been slowing.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of 2269 so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center